Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Xtant Medical Holdings, Inc. | Financial_Report.xls |
EX-4.2 - EXHIBIT 4.2 - Xtant Medical Holdings, Inc. | v402499_ex4-2.htm |
EX-32.2 - EXHIBIT 32.2 - Xtant Medical Holdings, Inc. | v402499_ex32-2.htm |
EX-31.1 - EXHIBIT 31.1 - Xtant Medical Holdings, Inc. | v402499_ex31-1.htm |
EX-32.1 - EXHIBIT 32.1 - Xtant Medical Holdings, Inc. | v402499_ex32-1.htm |
EX-10.4 - EXHIBIT 10.4 - Xtant Medical Holdings, Inc. | v402499_ex10-4.htm |
EX-31.2 - EXHIBIT 31.2 - Xtant Medical Holdings, Inc. | v402499_ex31-2.htm |
EX-10.9 - EXHIBIT 10.9 - Xtant Medical Holdings, Inc. | v402499_ex10-9.htm |
EX-10.1 - EXHIBIT 10.1 - Xtant Medical Holdings, Inc. | v402499_ex10-1.htm |
EX-10.10 - EXHIBIT 10.10 - Xtant Medical Holdings, Inc. | v402499_ex10-10.htm |
10-K - 10-K - Xtant Medical Holdings, Inc. | v402499_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements on Form S-3 (No. 333-194944, No. 333-189830 and No. 333-175469) and on Form S-8 (No. 333-172891, No. 333-187563, and No. 333-191248) of Bacterin International Holdings, Inc. (the “Company”) of our report dated March 18, 2015 relating to the Company’s consolidated financial statements as of and for the year ended December 31, 2014, which report appears in Item 8 of this Form 10-K.
/s/ EKS&H LLLP
March 18, 2015
Denver, Colorado